DEA schedule
Schedule III drugs list
Every substance the DEA controlled substances list places in Schedule III, and the FDA-listed prescription drugs in Schedule III.
Source: DEA Controlled Substances, Alphabetical Order file dated 2026-10-21. Publisher page
The DEA list places 129 substances in Schedule III (8 marked narcotic). 51 drugs with FDA prescription listings carry Schedule III in the NDC directory.
Run it in Rivvi
Which 2027 plans near you dropped or restricted your top drugs?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
FDA-listed Schedule III drugs
- Suboxonebuprenorphine and naloxone
- Buprenorphine and Naloxone104 NDC listings
- Testosterone Cypionate61 NDC listings
- Buprenorphine107 NDC listings
- Testosterone48 NDC listings
- Belbucabuprenorphine
- Spravatoesketamine
- Fycompaperampanel
- Zubsolvbuprenorphine and naloxone
- Butalbital, Aspirin and Caffeine5 NDC listings
- Dronabinol15 NDC listings
- Xyostedtestosterone enanthate
- Butransbuprenorphine
- Sublocadebuprenorphine
- Butalbital and Acetaminophen14 NDC listings
- Xywavsodium oxybate, calcium oxybate, potassium oxybate and magnesium oxybate
- Testosterone Enanthate5 NDC listings
- Brixadibuprenorphine
- Jatenzotestosterone undecanoate
- Ascomp with Codeinebutalbital, aspirin, caffeine and codeine
- Sodium Oxybate9 NDC listings
- Xyremsodium oxybate
- Depo-Testosteronetestosterone cypionate
- Lumryzsodium oxybate
- Testopeltestosterone
- Testimtestosterone
- Aveedtestosterone undecanoate
- Tlandotestosterone undecanoate
- Natestotestosterone
- Methyltestosterone3 NDC listings
- Methitestmethyltestosterone
- Trezixacetaminophen, caffeine and dihydrocodeine
- Acetaminophen and Codeine73 NDC listings
- Acetaminophen, Caffeine and Dihydrocodeine1 NDC listings
- Azmirotestosterone cypionate
- Benzphetamine6 NDC listings
- Butalbital, Acetaminophen and Caffeine61 NDC listings
- Butalbital, Acetaminophen, Caffeine and Codeine8 NDC listings
- Butalbital, Aspirin, Caffeine and Codeine4 NDC listings
- Codeine and Chlorpheniramine1 NDC listings
- Esketamine1 NDC listings
- Ketalarketamine
- Ketamine28 NDC listings
- Kyzatrextestosterone undecanoate
- Marinoldronabinol
- Perampanel40 NDC listings
- Phendimetrazine20 NDC listings
- Sodium Oxybate, Calcium Oxybate, Potassium Oxybate and Magnesium Oxybate1 NDC listings
- Testosterone Undecanoate8 NDC listings
- Tuxarincodeine and chlorpheniramine
- Vogelxotestosterone
DEA Schedule III substances
| Substance | DEA code | Narcotic | Other names |
|---|---|---|---|
| 1-Androstenediol (3α,17β-dihydroxy-5α-androst-1-ene) | 4000 | No | None |
| 1-Androstenediol (3β,17β-dihydroxy-5α-androst-1-ene) | 4000 | No | None |
| 1-Androstenedione (5α-androst-1-en-3,17-dione) | 4000 | No | None |
| 13β-Ethyl-17β-hydroxygon-4-en-3-one | 4000 | No | None |
| 17α-Methyl-3α,17β-dihydroxy-5α-androstane | 4000 | No | None |
| 17α-Methyl-3β,17β-dihydroxy-5α-androstane | 4000 | No | None |
| 17α-Methyl-3β,17β-dihydroxyandrost-4-ene | 4000 | No | None |
| 17α-Methyl-4-hydroxynandrolone (17α-methyl-4- | 4000 | No | None |
| 17α-Methyl-5α-androstan-17β-ol | 4000 | No | None |
| 17α-Methyl-androst-2-ene-3,17β-diol | 4000 | No | None |
| 17α-Methyl-androsta-1,4-diene-3,17β-diol | 4000 | No | None |
| 17α-Methyl-androstan-3-hydroxyimine-17β-ol | 4000 | No | None |
| 17α-Methyl-Δ1-dihydrotestosterone (17β-hydroxy-17α- | 4000 | No | 17α-Methyl-1-testosterone |
| 17β-Hydroxy-androstano[2,3-d]isoxazole | 4000 | No | None |
| 17β-Hydroxy-androstano[3,2-c]isoxazole | 4000 | No | None |
| 18a-Homo-3-hydroxy-estra-2,5(10)-dien-17-one | 4000 | No | None |
| 19-Nor-4,9(10)-androstadienedione (estra-4,9(10)- | 4000 | No | None |
| 19-Nor-4-androstenediol (3α,17β-dihydroxyestr-4-ene) | 4000 | No | None |
| 19-Nor-4-androstenediol (3β,17β-dihydroxyestr-4-ene) | 4000 | No | None |
| 19-Nor-4-androstenedione (estr-4-en-3,17-dione) | 4000 | No | None |
| 19-Nor-5-androstenediol (3α,17β-dihydroxyestr-5-ene) | 4000 | No | None |
| 19-Nor-5-androstenediol (3β,17β-dihydroxyestr-5-ene) | 4000 | No | None |
| 19-Nor-5-androstenedione (estr-5-en-3,17-dione) | 4000 | No | None |
| 2α,17α-Dimethyl-17β-hydroxy-5β-androstan-3-one | 4000 | No | None |
| 2α,3α-Epithio-17α-methyl-5α-androstan-17β-ol | 4000 | No | None |
| 3α,17β-Dihydroxy-5α-androstane | 4000 | No | None |
| 3β,17β-Dihydroxy-5α-androstane | 4000 | No | None |
| 3β-Hydroxy-estra-4,9,11-trien-17-one | 4000 | No | None |
| 4-Androstenediol (3β,17β-dihydroxy-androst-4-ene) | 4000 | No | 4-AD |
| 4-Androstenedione (androst-4-en-3,17-dione) | 4000 | No | None |
| 4-Chloro-17α-methyl-17β-hydroxy-androst-4-en-3-one | 4000 | No | None |
| 4-Chloro-17α-methyl-17β-hydroxy-androst-4-ene-3,11- | 4000 | No | None |
| 4-Chloro-17α-methyl-androst-4-ene-3β,17β-diol | 4000 | No | None |
| 4-Chloro-17α-methyl-androsta-1,4-diene-3,17β-diol | 4000 | No | None |
| 4-Dihydrotestosterone (17β-hydroxy-androstan-3-one) | 4000 | No | Anabolex; Andractim; Pesomax; Stanolone |
| 4-Hydroxy-19-nortestosterone (4,17β-dihydroxyestr-4- | 4000 | No | None |
| 4-Hydroxy-androst-4-ene-3,17-dione | 4000 | No | Listed as 4-Hydroxy-androst-4-ene-3,17-dione[3,2- |
| 4-Hydroxytestosterone (4,17β-dihydroxyandrost-4-en-3- | 4000 | No | None |
| 5-Androstenediol (3β,17β-dihydroxy-androst-5-ene) | 4000 | No | None |
| 5-Androstenedione (androst-5-en-3,17-dione) | 4000 | No | None |
| 5α-Androstan-3,17-dione | 4000 | No | Androstanedione |
| 5α-Androstan-3,6,17-trione | 4000 | No | None |
| 6-Bromo-androsta-1,4-diene-3,17-dione | 4000 | No | None |
| 6-Bromo-androstan-3,17-dione | 4000 | No | None |
| 6α-Methyl-androst-4-ene-3,17-dione | 4000 | No | None |
| Amobarbital & noncontrolled active ingred. | 2126 | No | None |
| Amobarbital suppository dosage form | 2126 | No | None |
| Anabolic steroids | 4000 | No | Any substance meeting the definition of anabolic |
| Aprobarbital | 2100 | No | Alurate |
| Barbituric acid derivative | 2100 | No | Barbiturates not specifically listed |
| Benzphetamine | 1228 | No | Didrex; Inapetyl |
| Bolasterone (7α,17α-dimethyl-17β-hydroxyandrost-4- | 4000 | No | None |
| Boldenone (17β-hydroxyandrost-1,4-diene-3-one) | 4000 | No | Equipoise; Parenabol; Vebonol; dehydrotestosterone |
| Boldione (androsta-1,4-diene-3,17-dione) | 4000 | No | None |
| Buprenorphine | 9064 | Yes | Buprenex; Temgesic; Subutex; Suboxone |
| Butabarbital (secbutabarbital) | 2100 | No | Butisol; Butibel |
| Butalbital | 2100 | No | Fiorinal; Butalbital with aspirin |
| Butobarbital (butethal) | 2100 | No | Soneryl (UK) |
| Calusterone (7β,17α-dimethyl-17β-hydroxyandrost-4- | 4000 | No | Methosarb |
| Chlorhexadol | 2510 | No | Mechloral; Mecoral; Medodorm; Chloralodol |
| Chlorphentermine | 1645 | No | Pre-Sate; Lucofen; Apsedon; Desopimon |
| Clortermine | 1647 | No | Voranil |
| Clostebol (4-chloro-17β-hydroxyandrost-4-en-3-one) | 4000 | No | Alfa-Trofodermin; Clostene; 4-chlorotestosterone |
| Codeine & isoquinoline alkaloid 90 mg/du | 9803 | Yes | Codeine with papaverine or noscapine |
| Codeine combination product 90 mg/du | 9804 | Yes | Empirin; Fiorinal; Tylenol; ASA or APAP w/codeine |
| Dehydrochloromethyltestosterone (4-chloro-17β- | 4000 | No | Oral-Turinabol |
| Desoxymethyltestosterone (17α-methyl-5α-androst-2- | 4000 | No | Madol |
| Dihydrocodeine combination product 90 mg/du | 9807 | Yes | Synalgos-DC; Compal |
| Dronabinol (synthetic) in sesame oil in soft gelatin | 7369 | No | Marinol; synthetic THC in sesame oil/soft gelatin as |
| Drostanolone (17β-hydroxy-2α-methyl-5α-androstan-3- | 4000 | No | Drolban; Masterid; Permastril |
| Embutramide | 2020 | No | Tributane |
| Estra-4,9,11-triene-3,17-dione | 4000 | No | None |
| Ethylestrenol (17α-ethyl-17β-hydroxyestr-4-ene) | 4000 | No | Maxibolin; Orabolin; Durabolin-O; Duraboral |
| Ethylmorphine combination product 15 mg/du | 9808 | Yes | None |
| Fluoxymesterone (9-fluoro-17α-methyl-11β,17β- | 4000 | No | Anadroid-F; Halotestin; Ora-Testryl |
| Formebolone (2-formyl-17α-methyl-11α,17β- | 4000 | No | Esiclene; Hubernol |
| Furazabol (17α-methyl-17β-hydroxyandrostano[2,3-c]- | 4000 | No | Frazalon; Miotolon; Qu Zhi Shu |
| Gamma Hydroxybutyric Acid preparations | 2012 | No | Xyrem |
| Ketamine | 7285 | No | Ketaset; Ketalar; Special K; K |
| Lysergic acid | 7300 | No | LSD precursor |
| Lysergic acid amide | 7310 | No | LSD precursor |
| Marijuana extract, as defined in 21 CFR | 7353 | No | None |
| Marijuana, as defined in 21 U.S.C. 802(16), in a U.S. | 7362 | No | None |
| Mestanolone (17α-methyl-17β-hydroxy-5α-androstan-3- | 4000 | No | Assimil; Ermalone; Methybol; Tantarone |
| Mesterolone (1α-methyl-17β-hydroxy-5α-androstan-3- | 4000 | No | Androviron; Proviron; Testiwop |
| Methandienone (17α-methyl-17β-hydroxyandrost-1,4- | 4000 | No | Dianabol; Metabolina; Nerobol; Perbolin |
| Methandriol (17α-methyl-3β,17β-dihydroxyandrost-5- | 4000 | No | Sinesex; Stenediol; Troformone |
| Methasterone (2α,17α-dimethyl-5α-androstan-17β-ol-3- | 4000 | No | Methasterone; 2α,17α-dimethyl-17β-hydroxy-5α- |
| Methenolone (1-methyl-17β-hydroxy-5α-androst-1-en-3- | 4000 | No | Primobolan; Primobolan Depot; Primobolan S |
| Methyldienolone (17α-methyl-17β-hydroxyestra-4,9(10)- | 4000 | No | None |
| Methyltestosterone (17α-methyl-17β-hydroxyandrost-4- | 4000 | No | Android; Oreton; Testred; Virilon |
| Methyltrienolone (17α-methyl-17β-hydroxyestra-4,9,11- | 4000 | No | Metribolone |
| Methyprylon | 2575 | No | Noludar |
| Mibolerone (7α,17α-dimethyl-17β-hydroxyestr-4-en-3- | 4000 | No | Cheque; Matenon |
| Morphine combination product/50 mg/(100 ml or 100 | 9810 | Yes | None |
| Nalorphine | 9400 | Yes | Nalline |
| Nandrolone (17β-hydroxyestr-4-en-3-one) | 4000 | No | Deca-Durabolin; Durabolin; Durabolin-50 |
| Naturally derived delta-9-tetrahydrocannabinols in a | 7386 | No | (i) Naturally derived delta-9-tetrahydrocannabinols |
| Norbolethone (13β,17α-diethyl-17β-hydroxygon-4-en-3- | 4000 | No | Genabol |
| Norclostebol (4-chloro-17β-hydroxyestr-4-en-3-one) | 4000 | No | Anabol-4-19; Lentabol |
| Norethandrolone (17α-ethyl-17β-hydroxyestr-4-en-3- | 4000 | No | Nilevar; Pronabol; Solevar |
| Normethandrolone (17α-methyl-17β-hydroxyestr-4-en-3- | 4000 | No | Lutenin; Matronal; Orgasteron |
| Opium combination product 25 mg/du | 9809 | Yes | Paregoric, other combination products |
| Oxandrolone (17α-methyl-17β-hydroxy-2-oxa-5α- | 4000 | No | Anavar; Lonavar; Oxandrin; Provitar |
| Oxymesterone (17α-methyl-4,17β-dihydroxyandrost-4- | 4000 | No | Anamidol; Balnimax; Oranabol; Oranabol 10 |
| Oxymetholone (17α-methyl-2-hydroxymethylene-17β- | 4000 | No | Anadrol-50; Adroyd; Anapolon; Anasteron |
| Pentobarbital & noncontrolled active ingred. | 2271 | No | FP-3 |
| Pentobarbital suppository dosage form | 2271 | No | WANS |
| Perampanel | 2261 | No | Fycompa; [2-(2-oxo-l-phenyl-5-pyridin-2-yl-l ,2- |
| Phendimetrazine | 1615 | No | Plegine; Prelu-2; Bontril; Melfiat |
| Prostanozol (17β-hydroxy-5α-androstano[3,2- | 4000 | No | Prostanozol; [3,2-c]pyrazole-5α-androstan-17β-ol |
| Secobarbital & noncontrolled active ingred | 2316 | No | None |
| Secobarbital suppository dosage form | 2316 | No | None |
| Stanozolol (17α-methyl-17β-hydroxy-5α-androst-2- | 4000 | No | Winstrol; Winstrol-V |
| Stenbolone (17β-hydroxy-2-methyl-5α-androst-1-en-3- | 4000 | No | None |
| Stimulant compounds previously excepted | 1405 | No | Mediatric |
| Sulfondiethylmethane | 2600 | No | None |
| Sulfonethylmethane | 2605 | No | None |
| Sulfonmethane | 2610 | No | None |
| Talbutal | 2100 | No | Lotusate |
| Testolactone (13-hydroxy-3-oxo-13,17-secoandrosta- | 4000 | No | Teolit; Teslac |
| Testosterone (17β-hydroxyandrost-4-en-3-one) | 4000 | No | Android-T; Androlan; Depotest; Delatestryl |
| Tetrahydrogestrinone (13β,17α-diethyl-17β-hydroxygon- | 4000 | No | THG |
| Thiamylal | 2100 | No | Surital |
| Thiopental | 2100 | No | Pentothal |
| Tiletamine & Zolazepam Combination Product | 7295 | No | Telazol |
| Trenbolone (17β-hydroxyestr-4,9,11-trien-3-one) | 4000 | No | Finaplix-S; Finajet; Parabolan |
| Vinbarbital | 2100 | No | Delvinal; vinbarbitone |
| Δ1-Dihydrotestosterone (17β-hydroxy-5α-androst-1-en- | 4000 | No | 1-Testosterone |